HomeAVIR • NASDAQ
add
Atea Pharmaceuticals Inc
Previous close
$3.70
Day range
$3.65 - $3.76
Year range
$2.77 - $5.19
Market cap
307.41M USD
Avg Volume
232.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 11.53M | -6.72% |
Net income | -39.16M | -13.75% |
Net profit margin | — | — |
Earnings per share | -0.47 | -14.63% |
EBITDA | -28.25M | -4.72% |
Effective tax rate | -0.90% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 578.11M | -10.61% |
Total assets | 594.97M | -10.76% |
Total liabilities | 39.78M | 52.19% |
Total equity | 555.19M | — |
Shares outstanding | 84.16M | — |
Price to book | 0.56 | — |
Return on assets | -11.78% | — |
Return on capital | -12.41% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -39.16M | -13.75% |
Cash from operations | -21.83M | -1.34% |
Cash from investing | 27.77M | -17.07% |
Cash from financing | 0.00 | — |
Net change in cash | 5.94M | -50.29% |
Free cash flow | 3.86M | 847.77% |
About
Founded
2012
Headquarters
Website
Employees
75